Veli-Matti Lehtola

Title: Veli-Matti Lehtola: Innovator in Oral Drug Formulations

Introduction

Veli-Matti Lehtola is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of oral drug formulations. With a total of four patents to his name, Lehtola's work has the potential to impact therapeutic practices.

Latest Patents

One of Lehtola's latest patents focuses on oral formulations of ospemifene. This invention pertains to a liquid or semisolid oral drug formulation that includes a therapeutically active compound, which may be a geometric isomer, a stereoisomer, a pharmaceutically acceptable salt, an ester, or a metabolite, combined with a pharmaceutically acceptable carrier. This innovative approach aims to enhance the delivery and efficacy of the drug.

Career Highlights

Throughout his career, Veli-Matti Lehtola has worked with various companies, including Hormos Medical Corporation and Quatrx Pharmaceuticals Company. His experience in these organizations has contributed to his expertise in pharmaceutical formulations and drug development.

Collaborations

Lehtola has collaborated with several professionals in his field, including Markku Anttila. These partnerships have likely enriched his research and development efforts, leading to advancements in his patented technologies.

Conclusion

Veli-Matti Lehtola stands out as an innovator in the pharmaceutical industry, particularly with his work on oral drug formulations. His contributions through patents and collaborations reflect his commitment to advancing medical science.